About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Michigan | 20,089 Studies Near You

Clinical TrialsMichigan

Clinical Trials in Michigan

Discover 20,089 clinical trials near Michigan. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 20,089 trials

CompletedAbraxane With Anti-PD1/PDL1 in Patients With Advanced Urothelial CancerThis is a phase 2, single arm, two-stage study of abraxane with an anti-PD1/PDL1 (pembrolizumab) in cisplatin-ineligible patients with advanced urothelial cancer.NCT03240016·Ann Arbor, Michigan CompletedSafety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFEThis was a multicenter, randomized (1:1 inhaled treprostinil: placebo), double-blinded, placebo-controlled trial to evaluate the safety and efficacy of inhaled treprostinil in…NCT02630316·Birmingham, Alabama and 96 others

Find Trials by Condition in Michigan

Breast Cancerin Michigan Lung Cancerin Michigan Prostate Cancerin Michigan Colorectal Cancerin Michigan Melanomain Michigan Leukemiain Michigan Lymphomain Michigan Pancreatic Cancerin Michigan Ovarian Cancerin Michigan Brain Cancerin Michigan Diabetes

Data from ClinicalTrials.govTerms

CompletedA Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected PatientsThe purpose of this study is to determine if two dose levels of indinavir combined with two nucleoside analogue reverse transcriptase inhibitors (NRTIs) have the same effect on…NCT00002406·Birmingham, Alabama and 28 others

CompletedA Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)The main purpose of this study is to evaluate the efficacy and safety of orforglipron on maintenance of body weight reduction in participants who previously completed treatment…NCT06584916·Birmingham, Alabama and 28 others

Active not recruitingA Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple MyelomaThe purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in…NCT05827016·Aurora, Colorado and 268 others

CompletedEfficacy Study of p38 Kinase Inhibitor to Treat Patients With AtherosclerosisThe purpose of the study is to determine whether a p38 kinase inhibitor reduces inflammation in atherosclerotic plaqueNCT00570752·Chiefland, Florida and 16 others

CompletedBinocular Dig Rush Game Treatment for AmblyopiaTo compare the efficacy of 1 hour/day of binocular game play 5 days per week plus spectacle correction with spectacle correction only, for treatment of amblyopia in children 4 to…NCT02983552·Birmingham, Alabama and 61 others

Active not recruitingA Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple MyelomaThis research study is studying a combination of study drugs as a possible treatment for relapsed and refractory Multiple Myeloma.NCT02718833·Boston, Massachusetts and 5 others

RecruitingA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityThe purpose of this clinical study is to learn about the effects and safety of berobenatide (PF-08653944). This may help people with overweight or obesity lose weight.NCT07595549·Canoga Park, California and 79 others

Active not recruitingBenralizumab Airway Remodeling Study in Severe Eosinophilic AsthmaticsThe purpose of the study is to evaluate effect of benralizumab on structural and lung function changes in severe eosinophilic asthmatics.NCT03953300·Birmingham, Alabama and 34 others

CompletedPre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce ReadmissionsHospital readmissions for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) pose burdens to the healthcare system and patients.NCT02135744·Detroit, Michigan

CompletedClot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase IIIThe overall objective of this Phase III clinical trial is to obtain information from a population of 500 ICH subjects with intraventricular hemorrhage (IVH), representative of…NCT00784134·Birmingham, Alabama and 80 others

CompletedA Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's DiseaseThe study hypothesis is to establish the safety and tolerability of long-term open-label (OL) CP-690,550 therapy in subjects with Crohn's disease.NCT01470599·Oceanside, California and 74 others

Active not recruitingEfficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)Researchers are looking for new ways to treat high-risk non muscle invasive bladder cancer (HR NMIBC).NCT03711032·Anchorage, Alaska and 208 others

TerminatedSteroid Sensitive Nephrotic Syndrome in ChildrenIdiopathic nephrotic syndrome (INS) is one of the most common glomerular pathologies in children and corticosteroid therapy is its most effective treatment.NCT03878914·Detroit, Michigan and 1 other

WithdrawnAn Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary CirrhosisOpen-label, multicenter study in adults with Primary Biliary Cirrhosis (PBC) designed to evaluate the long-term safety and tolerability of daily dosing with LUM001.NCT02321306·La Jolla, California and 17 others

RecruitingAn Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsThe primary objectives of this trial are to: * Characterize the safety and tolerability of TEV-56278 * Determine the Recommended Phase 2 Dose (RP2D) * Evaluate antitumor activity…NCT06480552·Los Angeles, California and 11 others

CompletedA Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated InfluenzaThe purpose of this study is to evaluate safety and tolerability of a single dose of MEDI8852 when given with oseltamivir, the safety and tolerability of oseltamivir alone, and…NCT02603952·Canoga Park, California and 30 others

RecruitingOpen-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)This is a Phase 3 global, multicenter, 52-week, open-label extension (OLE) rollover study for subjects completing study CN012-0026, CN012-0027 or CN012-0056.NCT05980949·Homewood, Alabama and 431 others

CompletedStudy of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's LymphomaThis study is sponsored by Sierra Oncology, Inc. formerly ProNAi Therapeutics, Inc. It study is a multi-center, nonrandomized, open-label, pilot Phase II investigation of PNT2258…NCT01733238·Lafayette, Indiana and 2 others

PreviousPage 5 of 1005Next

in Michigan

Heart Diseasein Michigan